🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Healthy Human Volunteers

Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge NCT02639299n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… A First-in-Human Single and Multiple Ascending Dose Study of MT-201 NCT07219368Phase 11 site📍 San Diego Mirador Therapeutics, Inc. · Tests: MT-201, Placebo Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body NCT06645691Phase 21 site📍 Singapore National Heart Centre Singapore · Tests: Hyperpolarized 13C-pyruvate SAR447971 First-in-human Study NCT07629336Phase 11 site📍 Leiden Sanofi · Tests: SAR447971, Placebo A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants NCT06682975Phase 11 site📍 Leiden Zealand Pharma · Tests: ZP9830, Placebo Investigating the Plasticity of Human Predictive Coding Through Neuromodulation NCT06374433NA1 site📍 Milan Università Vita-Salute San Raffaele · Tests: Occipital tACS at IAF-2Hz, Occipital tACS at IAF+2Hz, Frontal tACS at 4-7 Hz, Occipital tRNS, Frontal tRNS Screening for LID Clinical Studies Unit Healthy Volunteer Protocols NCT01386424n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Determination of Physical Parameters Relevant to Ophthalmic Lasers NCT02023073n/a1 site📍 Tel Litwinsky Sheba Medical Center Human Skin and Gut Mycobiome and Bacteriome Comprehensive Registry NCT05196061n/a1 site📍 Cleveland University Hospitals Cleveland Medical Center · Tests: Questionnaire, Stool sample, Skin swab, Oral rinse Mucosal and Systemic Immunity Correlates of Protection Against Influenza in Young Children, Aged 2-5 Years (MUSIC-Flu) NCT07861854n/a1 site📍 Jouberton National Institute for Communicable Diseases, South Africa Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia NCT07344948EARLY Phase 11 site📍 Los Alamitos Neurosterix · Tests: NTX-253, Placebo A Study to See How Safe a New Medicine (NNC0705-0002) is in Healthy People NCT07797855Phase 11 site📍 Groningen Novo Nordisk A/S · Tests: NNC0705-0002, Placebo Preliminary Human Trials of F230 Tablets NCT06899815Phase 11 site📍 Hubei Beijing Continent Pharmaceutical Co, Ltd. · Tests: F230 tablets Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation NCT06945614Phase 11 site📍 Boston General Biophysics LLC · Tests: Xenon gas inhalation A First-in Human Study of ARD001 in Healthy Volunteers and People With Hemophilia A NCT07787091Phase 1, Phase 21 site📍 Singapore Arditus Pte Ltd · Tests: ARD001, Placebo Phase 1a Study Assessing Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PMG1016 NCT07615985Phase 11 site📍 Brisbane Pulmongene Ltd. · Tests: PMG1016 Dose 1, PMG1016 Dose 2, PMG1016 Dose 3, PMG1016 Dose 4 A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers NCT07798505Phase 11 site📍 San Antonio Hemab ApS · Tests: HMB-003, Placebo First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients NCT07708116Phase 11 site📍 Groningen Centauri Therapeutics Limited · Tests: Placebo, CTX-187 SAD and MAD Study of AKB-9090 in Healthy Adult Participants NCT07429006Phase 11 site📍 Auckland Akebia Therapeutics · Tests: AKB-9090, Placebo "One All" to Get it RYT (Resilient Young Tribal Adults) NCT06474260NA2 sites📍 Chamrajnagar📍 Gudalur University of Pittsburgh · Tests: "One All" Intervention Deep Optical Imaging of Tissue (DOIT) NCT07754500NA1 site📍 Malmö Lund University · Tests: Mk1 A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants NCT07836452Phase 11 site📍 Melbourne City Therapeutics · Tests: CITY-RBP4, Placebo Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults NCT07363395Phase 11 site📍 Saint Paul Alcamena Stem Cell Therapeutics · Tests: ASCT-83, Placebo Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease NCT07235059Phase 12 sites📍 Miami📍 Berlin Novartis Pharmaceuticals · Tests: OJR520, Placebo Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection NCT07706686Phase 11 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: rDEN2delta30-7169 A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma NCT07660731Phase 11 site📍 New Haven Pfizer · Tests: PF-08103402, Placebo, Midazolam A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE) NCT06917742Phase 13 sites📍 Herston📍 Bayswater📍 Nedlands Capstan Therapeutics · Tests: CPTX2309, CPTX2309 GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE NCT06620185NA1 site📍 London Imperial College London · Tests: FLUENZ, Influenza challenge virus A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects NCT05913752Phase 1, Phase 24 sites📍 New Haven📍 Baltimore📍 Jerusalem Clearmind Medicine Inc. · Tests: CMND-100 A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP) NCT07408232Phase 1, Phase 22 sites📍 Portland📍 Dallas Octant, Inc. · Tests: Phase 1b/2: Cohort 1 - OCT-980 Tablet, Phase 1b/2: Cohort 2 - OCT-980 Tablet, Phase 1b/2: Cohort 3 - OCT-980 Tablet, Ph…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy